Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Merete Lindegaard

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|September 18, 2008
[Smoking--a risk factor for rheumatoid arthritis development]Anne Friesgaard Christensen, Hanne Merete Lindegaard, Peter Junker
Ugeskrift for Laeger|November 25, 2005
[Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics]Hanne Merete Lindegaard, Kim Hørslev-Petersen, Peter Junker
Ugeskrift for Laeger|January 30, 2009
[Carotinaemia in patient with excessive beta-carotene food-intake and dysregulated diabetes mellitus]Carsten Sauer Mikkelsen, Dorthe Bisgaard Mikkelsen, Hanne Merete Lindegaard
Danish Medical Bulletin|April 7, 2011
Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritisAnna Christine Nilsson, Anne Friesgaard Christensen, Peter Junker, et al.
Danish Medical Journal|February 14, 2020
Use and utility of serologic tests for rheumatoid arthritis in primary careHelene Broch Tenstad, Anna Christine Nilsson, Christoffer Dalsgaard Dellgren, et al.
Arthritis and Rheumatism|April 13, 2011
Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritisAnne Duer-Jensen, Kim Hørslev-Petersen, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|March 29, 2007
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?Elisabeth Hjardem, Mikkel Østergaard, Jan Pødenphant, et al.
Danish Medical Journal|March 23, 2022
A retrospective cohort study of patients with eosinophilia referred to a tertiary centreMette Hougaard, Gundhild Nynke Thomsen, Thomas Kielsgaard Kristensen, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Frontiers in Oncology|June 5, 2023
The multidisciplinary approach to eosinophiliaGunhild Nynke Thomsen, Mette Niemann Christoffersen, Hanne Merete Lindegaard, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|September 18, 2008
[Smoking--a risk factor for rheumatoid arthritis development]Anne Friesgaard Christensen, Hanne Merete Lindegaard, Peter Junker
Ugeskrift for Laeger|November 25, 2005
[Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics]Hanne Merete Lindegaard, Kim Hørslev-Petersen, Peter Junker
Ugeskrift for Laeger|January 30, 2009
[Carotinaemia in patient with excessive beta-carotene food-intake and dysregulated diabetes mellitus]Carsten Sauer Mikkelsen, Dorthe Bisgaard Mikkelsen, Hanne Merete Lindegaard
Danish Medical Bulletin|April 7, 2011
Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritisAnna Christine Nilsson, Anne Friesgaard Christensen, Peter Junker, et al.
Danish Medical Journal|February 14, 2020
Use and utility of serologic tests for rheumatoid arthritis in primary careHelene Broch Tenstad, Anna Christine Nilsson, Christoffer Dalsgaard Dellgren, et al.
Arthritis and Rheumatism|April 13, 2011
Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritisAnne Duer-Jensen, Kim Hørslev-Petersen, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|March 29, 2007
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?Elisabeth Hjardem, Mikkel Østergaard, Jan Pødenphant, et al.
Danish Medical Journal|March 23, 2022
A retrospective cohort study of patients with eosinophilia referred to a tertiary centreMette Hougaard, Gundhild Nynke Thomsen, Thomas Kielsgaard Kristensen, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Frontiers in Oncology|June 5, 2023
The multidisciplinary approach to eosinophiliaGunhild Nynke Thomsen, Mette Niemann Christoffersen, Hanne Merete Lindegaard, et al.
Pageof 2